Our team — About us — Novalgen
NovalGen is an innovative immuno-oncology company developing breakthrough bispecific therapies that can safely harness the immune system to fight cancer. NovalGen is focused on the development of cutting-edge, proprietary treatments for patients with hematologic malignancies and solid tumors by developing therapeutics that treat cancer using our breakthrough technologies in Bispecific antibodies and beyond. Our mission is to create life-enhancing and curative new treatments for people with cancer. Headquartered in London, UK, NovalGen was formed in 2019. NovalGen is guided by our core set of values. The culture of NovalGen reflects these values and they help guide our decisions. NovalGen’s first pipeline product is a proprietary first in class bispecific T cell engager therapies that can safely harness the immune system to fight a wide range of cancers. We are changing the paradigm of cancer therapy with our immunotherapy technology.
This company is:
Verified
Our technologies — Novalgen
Our immunotherapy technology focuses on the next generation of bispecific antibody technology to generate transformative outcomes in patients with cancer.
Verified
Key capabilities — Our technologies — Novalgen
Key capabilities | Protein engineering | CMC | More in this section | Our technologies | Auto-regulation
View all products
Keywords
Industries
Where is NovalGen located?
The company NovalGen is located in London, England, United Kingdom. It's worth noting that the company may has more corporate locations
How many employees does NovalGen approximately have?
As of the latest available information NovalGen has around 11-50 employees worldwide.
When was NovalGen founded?
NovalGen was founded in 2019
In which industries does NovalGen mainly work?
The company NovalGen has it's main focus in the industries of Biotechnology
NOVIGENIX
Switzerland
11-50 Employees
2014
Novugen Pharma
Malaysia
501-1000 Employees
NovaGo Therapeutics
Switzerland
1-10 Employees
2015
Genenta Science
Italy
1-10 Employees
2014
Exinda Therapeutics, LLC
United States
1-10 Employees
2013
Virogin Biotech
Canada
11-50 Employees
2015
Leukemia & Lymphoma Society
1-10 Employees
1944
Glycanova AS
Norway
1-10 Employees
2009
Topics which have been searched by others and may be interesting for you:
